Smith & Nephew SNATS Market Cap 2006-2020 | SNN

Smith & Nephew SNATS market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Smith & Nephew SNATS market cap as of November 26, 2020 is $16.62B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.621B $5.138B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $188.597B 33.78
Medtronic (MDT) Ireland $152.313B 30.96
Stryker (SYK) United States $87.830B 32.87
Boston Scientific (BSX) United States $48.041B 28.19
Lonza Group Ag (LZAGY) Switzerland $45.106B 0.00
Baxter (BAX) United States $38.511B 23.13
Zimmer Biomet Holdings (ZBH) United States $31.025B 25.54
EssilorLuxottica Societe Anonyme (ESLOY) France $30.982B 0.00
Terumo (TRUMY) Japan $30.654B 39.18
ResMed (RMD) United States $29.857B 40.40
Sunny Optical Technology (SNPTF) China $22.266B 0.00
Insulet (PODD) United States $16.407B 565.59
Bio-Rad Laboratories (BIO) United States $15.608B 59.19
DiaSorin S.p.A (DSRLF) Italy $11.190B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
GN STORE NORD (GNNDY) Denmark $10.027B 51.11
Canopy Growth (CGC) Canada $9.997B 0.00
William Demant Holdings (WILYY) Denmark $8.605B 0.00
Quidel (QDEL) United States $7.604B 18.95
Perrigo (PRGO) Ireland $6.542B 11.52
Hill-Rom Holdings (HRC) United States $6.379B 17.26
Haemonetics (HAE) United States $5.728B 41.62
Envista Holdings (NVST) United States $4.649B 31.31
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.143B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.962B 0.00
Neogen (NEOG) United States $3.917B 64.21
ICU Medical (ICUI) United States $3.880B 29.12
TG Therapeutics (TGTX) United States $3.878B 0.00
National Vision Holdings (EYE) United States $3.588B 94.21
Agios Pharmaceuticals (AGIO) United States $3.162B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.675B 135.64
NuVasive (NUVA) United States $2.439B 35.23
NanoString Technologies (NSTG) United States $2.048B 0.00
Aphria (APHA) Canada $2.024B 0.00
AtriCure (ATRC) United States $1.964B 0.00
Owens & Minor (OMI) United States $1.847B 19.48
Cardiovascular Systems (CSII) United States $1.416B 0.00
InMode (INMD) Israel $1.394B 31.36
Quanterix (QTRX) United States $1.328B 0.00
MacroGenics (MGNX) United States $1.284B 0.00
Aurora Cannabis (ACB) Canada $1.231B 0.00
BioLife Solutions (BLFS) United States $1.080B 1100.00
Cerus (CERS) United States $1.006B 0.00
Lantheus Holdings (LNTH) United States $0.869B 15.48
LeMaitre Vascular (LMAT) United States $0.840B 44.38
PetIQ (PETQ) United States $0.835B 47.72
BellRing Brands (BRBR) United States $0.829B 35.03
OraSure Technologies (OSUR) United States $0.806B 0.00
Phibro Animal Health (PAHC) United States $0.780B 16.63
Meridian Bioscience (VIVO) United States $0.765B 16.60
Omeros (OMER) United States $0.722B 0.00
Varex Imaging (VREX) United States $0.653B 185.44
Vapotherm (VAPO) United States $0.620B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.606B 43.06
Surmodics (SRDX) United States $0.530B 324.42
Zynex (ZYXI) United States $0.466B 43.29
HEXO (HEXO) $0.382B 0.00
Viemed Healthcare (VMD) United States $0.364B 12.94
Cytosorbents (CTSO) United States $0.354B 0.00
Utah Medical Products (UTMD) United States $0.327B 29.82
Surface Oncology (SURF) United States $0.315B 0.00
Organigram Holdings (OGI) Canada $0.283B 0.00
Bovie Medical (APYX) United States $0.262B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Chimerix (CMRX) United States $0.231B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.224B 0.00
Wound Management Technologies (SMTI) United States $0.214B 0.00
Female Health (VERU) United States $0.211B 0.00
Exagen (XGN) United States $0.185B 0.00
Liberty Health Sciences (LHSIF) United States $0.130B 0.00
Evolus (EOLS) United States $0.127B 0.00
Fonar (FONR) United States $0.126B 18.42
Chembio Diagnostics (CEMI) United States $0.108B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.097B 0.00
Rockwell Medical (RMTI) United States $0.093B 0.00
Trinity Biotech (TRIB) Ireland $0.093B 7.17
Capricor Therapeutics (CAPR) United States $0.082B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.076B 0.00
United-Guardian (UG) United States $0.070B 16.94
Brainsway (BWAY) Israel $0.069B 0.00
MTech Acquisition (KERN) United States $0.068B 0.00
Nephros (NEPH) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
GUARDION HEALTH (GHSI) United States $0.022B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.019B 0.00
FSD PHARMA INC (HUGE) Canada $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00